Chinese contract development and manufacturing organisation (CDMO) Healsun Biopharm has raised nearly 250 million yuan ($36.7 million) in a Series B round. Separately, Warburg Pincus and Macquarie Asset Management are reportedly close to making an investment of about $450 million in China’s Bohao Internet Data Services.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
